tiprankstipranks
Rocket Pharma (DE:9IP1)
NASDAQ:9IP1
Germany Market
9IP1
Rocket Pharmaceuticals
RESEARCH TOOLSreports

Rocket Pharmaceuticals (9IP1) Stock News & Sentiment

3 Followers
Balancing Early Gene Therapy Validation Against Limited Near-Term Revenue and Pipeline Risk: Rationale for Maintaining a Hold on Rocket
Premium
Ratings
Balancing Early Gene Therapy Validation Against Limited Near-Term Revenue and Pipeline Risk: Rationale for Maintaining a Hold on Rocket
12d ago
RCKT
Rocket Pharmaceuticals: FDA Validation, Non-Dilutive Funding Catalyst, and Pipeline De-Risking Support Buy Rating
Premium
Ratings
Rocket Pharmaceuticals: FDA Validation, Non-Dilutive Funding Catalyst, and Pipeline De-Risking Support Buy Rating
15d ago
RCKT
Rocket Pharmaceuticals: Kresladi Approval, Non‑Dilutive Capital, and Danon Pipeline Progress Underscore Buy Rating Despite Share Weakness
Premium
Ratings
Rocket Pharmaceuticals: Kresladi Approval, Non‑Dilutive Capital, and Danon Pipeline Progress Underscore Buy Rating Despite Share Weakness
15d ago
RCKT
Rocket Pharmaceuticals: First Approval and Extended Cash Runway Offset by Long Path to Meaningful Kresladi Revenues, Warranting a Hold Rating
Premium
Ratings
Rocket Pharmaceuticals: First Approval and Extended Cash Runway Offset by Long Path to Meaningful Kresladi Revenues, Warranting a Hold Rating
15d ago
RCKT
Rocket Pharmaceuticals wins FDA nod for KRESLADI gene therapy
Premium
Company Announcements
Rocket Pharmaceuticals wins FDA nod for KRESLADI gene therapy
15d ago
8K
RCKT
Rocket Pharmaceuticals: FDA Approval of Kresladi Marks Strategic Inflection Point Supporting Buy Rating
Premium
Ratings
Rocket Pharmaceuticals: FDA Approval of Kresladi Marks Strategic Inflection Point Supporting Buy Rating
15d ago
RCKT
Rocket Pharma Advances BAG3 Heart Disease Study, Bolstering Long-Term Gene Therapy Story
Premium
Company Announcements
Rocket Pharma Advances BAG3 Heart Disease Study, Bolstering Long-Term Gene Therapy Story
22d ago
RCKT
More DE:9IP1 News >

9IP1 News on the Web

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Rocket Pharmaceuticals (RCKT) and Moderna (MRNA)
TipRanks News
Neutral
RCKT Stock Down Despite FDA Nod to Gene Therapy in Rare Disease
Zacks
Bearish
Rocket Pharmaceuticals price target raised to $9 from $8 at BofA
TipRanks News
Bullish
Balancing Early Gene Therapy Validation Against Limited Near-Term Revenue and Pipeline Risk: Rationale for Maintaining a Hold on Rocket
TipRanks News
Neutral
Rocket Pharmaceuticals price target raised to $11 from $9 at Leerink
TipRanks News
Bullish
PRV reception could net Rocket $100M-$200M, says LifeSci Capital
TipRanks News
Bullish
Rocket Pharmaceuticals stock weakness unwarranted, says Wedbush
TipRanks News
Bullish
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
DE:9IP1
Sector Average
Media Buzz
This Week1 articles
Weekly Average5.25 articles
News Sentiment
This Week50%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:9IP1’s Media Buzz Sentiment?
1 articles about DE:9IP1 were published this week. In an average week, 5.25 articles are published.
    What is DE:9IP1’s weekly average amount of articles?
    In an average week, 5.25 articles about DE:9IP1 are published.
      What is DE:9IP1’s News Sentiment?
      50% of articles about DE:9IP1 were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        AORTArtivion
        NBIXNeurocrine
        STAAStaar Surgical
        SLPSimulations Plus
        OWLTOwlet
        Showing the stocks with the most bullish news sentiment over the past week